Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $350.83 | 7 | 76.0% |
| Travel and Lodging | $110.50 | 1 | 24.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $155.13 | 1 | $0 (2022) |
| SPR Therapeutics, Inc | $128.50 | 2 | $0 (2023) |
| Boston Scientific Corporation | $113.13 | 2 | $0 (2023) |
| Amgen Inc. | $25.76 | 1 | $0 (2019) |
| Stryker Corporation | $25.01 | 1 | $0 (2017) |
| Fresenius Kabi USA, LLC | $13.80 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $13.80 | 1 | Fresenius Kabi USA, LLC ($13.80) |
| 2023 | $241.63 | 4 | SPR Therapeutics, Inc ($128.50) |
| 2022 | $155.13 | 1 | Abbott Laboratories ($155.13) |
| 2019 | $25.76 | 1 | Amgen Inc. ($25.76) |
| 2017 | $25.01 | 1 | Stryker Corporation ($25.01) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/26/2024 | Fresenius Kabi USA, LLC | — | Food and Beverage | In-kind items and services | $13.80 | General |
| 11/10/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $99.43 | General |
| Category: General - Pain Management_NMD | ||||||
| 11/10/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: General - Pain Management_NMD | ||||||
| 01/24/2023 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Travel and Lodging | Cash or cash equivalent | $110.50 | General |
| Category: Pain management | ||||||
| 01/21/2023 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $18.00 | General |
| Category: Pain management | ||||||
| 04/25/2022 | Abbott Laboratories | AXIUM (Device) | Food and Beverage | In-kind items and services | $155.13 | General |
| Category: Neuromodulation | ||||||
| 10/04/2019 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $25.76 | General |
| Category: Neuroscience | ||||||
| 01/12/2017 | Stryker Corporation | IVS - AutoPlex System (Device) | Food and Beverage | Cash or cash equivalent | $25.01 | General |
| Category: Interventional Spine | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 173 | 243 | $251,480 | $21,340 |
| 2022 | 3 | 152 | 168 | $154,117 | $15,065 |
| 2021 | 8 | 351 | 430 | $272,321 | $31,258 |
| 2020 | 9 | 310 | 393 | $238,097 | $26,804 |
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 68 | 124 | $60,760 | $10,226 | 16.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 52 | 52 | $37,440 | $6,018 | 16.1% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Facility | 2023 | 31 | 41 | $101,480 | $2,676 | 2.6% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2023 | 22 | 26 | $51,800 | $2,420 | 4.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 62 | 62 | $41,852 | $7,191 | 17.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 76 | 89 | $37,515 | $6,172 | 16.5% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2022 | 14 | 17 | $74,750 | $1,701 | 2.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 108 | 165 | $61,364 | $11,588 | 18.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 83 | 83 | $47,794 | $7,248 | 15.2% |
| 64483 | Injections of anesthetic and/or steroid drug into lower or sacral spine nerve root using imaging guidance, single level | Office | 2021 | 29 | 32 | $50,415 | $2,801 | 5.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 38 | 40 | $14,720 | $2,039 | 13.9% |
| 64493 | Injections of lower or sacral spine facet joint using imaging guidance, single level | Office | 2021 | 15 | 22 | $24,700 | $1,812 | 7.3% |
| 27096 | Injection procedure into sacroiliac joint for anesthetic or steroid | Office | 2021 | 21 | 22 | $33,057 | $1,746 | 5.3% |
| 62323 | Injection of substance into spinal canal of lower back or sacrum using imaging guidance | Office | 2021 | 18 | 19 | $18,430 | $1,411 | 7.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 14 | 14 | $7,991 | $1,332 | 16.7% |
| 64494 | Injections of lower or sacral spine facet joint using imaging guidance, second level | Office | 2021 | 11 | 18 | $10,235 | $987.00 | 9.6% |
| 76942 | Ultrasonic guidance imaging supervision and interpretation for insertion of needle | Office | 2021 | 14 | 15 | $3,615 | $294.88 | 8.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 69 | 107 | $39,061 | $5,899 | 15.1% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 59 | 59 | $33,223 | $4,734 | 14.2% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 45 | 45 | $25,584 | $4,293 | 16.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 37 | 60 | $21,912 | $3,167 | 14.5% |
| 64483 | Injections of anesthetic and/or steroid drug into lower or sacral spine nerve root using imaging guidance | Facility | 2020 | 21 | 26 | $43,274 | $2,652 | 6.1% |
| 64493 | Injections of lower or sacral spine facet joint using imaging guidance | Facility | 2020 | 15 | 21 | $26,790 | $1,981 | 7.4% |
| 64494 | Injections of lower or sacral spine facet joint using imaging guidance | Facility | 2020 | 14 | 20 | $11,655 | $1,157 | 9.9% |
| 62323 | Injection of substance into spinal canal of lower back or sacrum using imaging guidance | Facility | 2020 | 11 | 13 | $12,404 | $923.56 | 7.4% |
About Dr. Amy Pearson, MD
Dr. Amy Pearson, MD is a Pain Medicine healthcare provider based in Cudahy, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2012. The National Provider Identifier (NPI) number assigned to this provider is 1831457357.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amy Pearson, MD has received a total of $461.33 in payments from pharmaceutical and medical device companies, with $13.80 received in 2024. These payments were reported across 8 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($350.83).
As a Medicare-enrolled provider, Pearson has provided services to 986 Medicare beneficiaries, totaling 1,234 services with total Medicare billing of $94,467. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Practice Information
- Specialty Pain Medicine
- Other Specialties Pain Medicine, Interventional Pain Medicine
- Location Cudahy, WI
- Active Since 05/03/2012
- Last Updated 05/15/2025
- Taxonomy Code 207LP2900X
- Entity Type Individual
- NPI Number 1831457357
Products in Payments
- AXIUM (Device) $155.13
- SPRINT PNS System (Device) $128.50
- Aimovig (Biological) $25.76
- IVS - AutoPlex System (Device) $25.01
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.